Psoriasis Association of Singapore
  • Home
  • About Psoriasis
  • About Us
  • Events
  • Newsletter
  • PsoProtectMe
  • Contact

Meet the Team

Picture

Who We Are

The Psoriasis Association of Singapore (PAS) is a non-profitable organisation formed in 1982 with the encouragement and support from the late Professor V.S.Rajan. 

Since then, the Association is run by volunteers who are either Psoriasis patients or relatives of patient, professionals, nurses/staff and social workers from National Skin Centre. Doctors from National Skin Centre and from the private sectors are invited to be our Medical Consultants. The Association has also received much support from members of the dermatology profession and the Dermatology Society of Singapore.

Our Objective

PAS's objective to disseminate medical information and support to a group of members who are suffering from the chronic skin condition. It is an avenue for patients to meet to discuss and exchange ideas on how to cope on living with psoriasis. It aims to foster co-ordination and development of all activities in relation to psoriasis. And to promote the study of the causes and treatment of psoriasis and to disseminate medical information concerning psoriasis.

Support Group

The Support Group exists to meet the social and emotional needs of patients afflicted with psoriasis who are receiving treatment at our Centre. It is an extended arm of the work of the Medical Social Work Department in that it helps to complement the one-to-one counselling approach of the MSWs. The group functions on a voluntary basis where it serves as a platform for discussion of psychosocial issues pertaining to psoriasis and for purposeful activities that will foster experiential learning of coping with psoriasis.

PsoProtectMe is a partner organization of Psoriasis Association of Singapore. PsoProtectMe seeks to understand the experiences, symptoms and health behaviours of individuals with psoriasis during the pandemic. Along with PsoProtect (an international registry for health care providers to report outcomes of COVID-19 in individuals with psoriasis), it will help to determine how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating patients with psoriasis during the pandemic.
​
Designed by Psoriasis Association Singapore
  • Home
  • About Psoriasis
  • About Us
  • Events
  • Newsletter
  • PsoProtectMe
  • Contact